AI-generated summary
The authors report a single-blind pilot randomized trial of a brain photobiomodulation device (RGn550) in 50 sportspeople with acute concussion, comparing 5 Hz and 10 Hz pulse frequencies. Adverse device effects were mild and resolved in both groups, and no difference was detected between groups. Secondary outcomes were exploratory, without a sham comparator, so they are described as hypothesis-generating only.
- Participants
- 50
- Who or what was studied
- Adult sportspeople with acute sport-related concussion, treated within 72 hours of injury
- Limits stated in the abstract
- The study was a small pilot with no sham comparator, was not powered to establish equivalence, and secondary analyses were exploratory and unadjusted for multiplicity.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on frontiersin.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Sham, Trial registration, Primary outcome, Pilot study, Sample size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.